Canada pot grower Tilray enters pharma deal with Novartis’ Sandoz By Admin on December 19, 2018 Investors welcomed the news, with Tilray shares leaping nearly 10 percent on New York’s Nasdaq index as of 1530 GMT. Original source: https://health.economictimes.indiatimes.com/news/pharma/canada-pot-grower-tilray-enters-pharma-deal-with-novartis-sandoz/67154373?utm_source=RSS&utm_medium=ETRSS Also Read: Insulin Gains New Pathway to Increased Competition : USFDA Published in Industry News Health NewsPharma ArticlesPharma News Admin More from Industry NewsMore posts in Industry News »Zydus cuts price of generic remdesivirFrench pharma firm guilty of fraud, manslaughter over weight loss pill: courtEquity indices swing higher, metal and pharma stocks gainFrench pharma giant faces verdict on weight loss pill deaths